Stock Research: Dis-Chem Pharmacies

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Dis-Chem Pharmacies

JSE:DCP ZAE000227831
41
  • Value
    40
  • Growth
    83
  • Safety
    Safety
    17
  • Combined
    42
  • Sentiment
    40
  • 360° View
    360° View
    41
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Dis-Chem Pharmacies Limited is a South Africa-based company retailing and wholesaling affordable healthcare products and pharmaceuticals. It operates in the retail and wholesale industries. The company operates in South Africa. In the last fiscal year, the company had a market cap of $1,546 million, profits of $472 million, and revenue of $2,100 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 41 (better than 41% compared with alternatives), overall professional sentiment and financial characteristics for the stock Dis-Chem Pharmacies are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Dis-Chem Pharmacies. The consolidated Growth Rank has a good rank of 83, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 83% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 17 means that the share price of Dis-Chem Pharmacies is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 83% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 40, which means that the company has a riskier financing structure than 60% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 40, indicating professional investors are more pessimistic about the stock than for 60% of alternative investment opportunities. ...read more

more
Index
JSE All Shares
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 15 23 23
Growth
83 97 57 53
Safety
Safety
40 47 56 38
Sentiment
40 70 27 43
360° View
360° View
41 75 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
56 70 54 17
Opinions Change
40 50 29 50
Pro Holdings
n/a 83 31 65
Market Pulse
27 41 40 52
Sentiment
40 70 27 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
17 15 23 23
Growth
83 97 57 53
Safety Safety
40 47 56 38
Combined
42 57 36 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
22 25 31 33
Price vs. Earnings (P/E)
47 49 50 43
Price vs. Book (P/B)
15 15 18 13
Dividend Yield
23 32 39 33
Value
17 15 23 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
85 86 70 56
Profit Growth
58 74 44 50
Capital Growth
74 96 41 17
Stock Returns
67 69 55 85
Growth
83 97 57 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
34 31 36 28
Refinancing
47 52 53 51
Liquidity
56 57 60 47
Safety Safety
40 47 56 38

Similar Stocks

Discover high‑ranked alternatives to Dis-Chem Pharmacies and broaden your portfolio horizons.

Exxaro

JSE:EXX
Country: South Africa
Industry: Coal & Consumable Fuels
Size: Medium
Full Stock Analysis

Tiger Brands

JSE:TBS
Country: South Africa
Industry: Packaged Foods & Meats
Size: Medium
Full Stock Analysis

Harmony

JSE:HAR
Country: South Africa
Industry: Gold Production
Size: Large
Full Stock Analysis

Puregold Price Club

PSE:PGOLD
Country: Philippines
Industry: Hypermarkets, Super Centers
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.